Drug intelligence / Profile preview

terbutaline + ambroxol + guaifenesin + menthol

Development stage
Unknown
Lead developer
Vin Medicament
Modality
Small Molecules
Administration
Oral
01

Overview

KUFTIN-SF is a sugar-free, multi-ingredient expectorant and bronchodilator syrup developed and marketed by Vin Medicament. It is designed for the management of productive cough associated with various respiratory conditions, including bronchial asthma, acute and chronic bronchitis, and other obstructive airway diseases. The combination therapy utilizes four active components: terbutaline, a selective beta-2 adrenergic agonist that facilitates bronchodilation; ambroxol, a mucolytic agent that reduces mucus viscosity and enhances surfactant production; guaifenesin, an expectorant that increases the volume of respiratory tract secretions to aid their removal; and menthol, which provides a cooling effect and acts as a mild local anesthetic to relieve throat irritation. As a sugar-free formulation, KUFTIN-SF is specifically intended for patients who must monitor their glycemic levels, such as those with diabetes mellitus.

Brand names
KUFTIN-SF
Other names
KUFTIN-SF Sugar Free Syrup
02

Targets

ADRB2 (β2)

Beyond the preview

Go deeper on terbutaline + ambroxol + guaifenesin + menthol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on terbutaline + ambroxol + guaifenesin + menthol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call